Eloxx Pharmaceuticals, Inc.
ELOX
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 17.25% | 30.32% | 1.41% | 15.84% | 29.29% |
| Total Depreciation and Amortization | 1.62% | -0.54% | 4.49% | -5.82% | 45.38% |
| Total Amortization of Deferred Charges | 6.38% | -60.83% | -16.67% | 3.60% | 3.73% |
| Total Other Non-Cash Items | -74.92% | -39.57% | 67.66% | -8.73% | 3.75% |
| Change in Net Operating Assets | -117.49% | 174.97% | -605.93% | 37.21% | -1,203.03% |
| Cash from Operations | -66.99% | 69.68% | -20.37% | 18.50% | 28.74% |
| Capital Expenditure | -- | -- | -- | 100.00% | -585.71% |
| Sale of Property, Plant, and Equipment | 1,564.29% | 27.27% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1,564.29% | 27.27% | -- | 100.00% | -585.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 142.23% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -79.20% | -- |
| Cash from Financing | 157.00% | 119.04% | -2,503.85% | -79.20% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.60% | 95.64% | -167.40% | 2.64% | 43.67% |